PROPOFOL KABI 20 mg/ml, injectable emulsion 10 bottles of 100 ml
Active ingredients: Propofol
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Emulsion for injection or infusion10 bottles of 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPOFOL KABI 20 mg/mL, émulsion injectable
- Pharmaceutical form
- émulsion injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 100 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Jan 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65591412CIP75507547CIP133400955075479Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPOFOLémulsion | 20 mg · 1 mL d'émulsion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.